226 related articles for article (PubMed ID: 37888087)
1. The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer.
Kay C; Martinez-Perez C; Dixon JM; Turnbull AK
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888087
[TBL] [Abstract][Full Text] [Related]
2. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
3. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
4. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.
Castagnetta L; Traina A; Carruba G; Fecarotta E; Palazzotto G; Leake R
Br J Cancer; 1992 Jul; 66(1):167-70. PubMed ID: 1637667
[TBL] [Abstract][Full Text] [Related]
6. Prediction of nodal metastasis and prognosis of breast cancer by ANN-based assessment of tumour size and p53, Ki-67 and steroid receptor expression.
Mojarad S; Venturini B; Fulgenzi P; Papaleo R; Brisigotti M; Monti F; Canuti D; Ravaioli A; Woo L; Dlay S; Sherbet GV
Anticancer Res; 2013 Sep; 33(9):3925-33. PubMed ID: 24023330
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
9. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.
Kamby C; Rasmussen BB; Kristensen B
Br J Cancer; 1989 Aug; 60(2):252-7. PubMed ID: 2765376
[TBL] [Abstract][Full Text] [Related]
11. Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.
Kurbasic E; Sjöström M; Krogh M; Folkesson E; Grabau D; Hansson K; Rydén L; Waldemarson S; James P; Niméus E
Clin Proteomics; 2015; 12(1):13. PubMed ID: 25991917
[TBL] [Abstract][Full Text] [Related]
12. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
14. Axillary nodal metastatic burden in patients with breast cancer with clinically positive axillary nodes.
Niinikoski L; Hukkinen K; Leidenius MHK; Heikkilä P; Mattson J; Meretoja TJ
Br J Surg; 2020 Nov; 107(12):1615-1624. PubMed ID: 32492194
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement.
Manning DL; Robertson JF; Ellis IO; Elston CW; McClelland RA; Gee JM; Jones RJ; Green CD; Cannon P; Blamey RW
Eur J Cancer; 1994; 30A(5):675-8. PubMed ID: 8080686
[TBL] [Abstract][Full Text] [Related]
16. Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Chakraborty A; Bose CK; Basak J; Sen AN; Mishra R; Mukhopadhyay A
Indian J Med Res; 2016 May; 143(Supplement):S45-S51. PubMed ID: 27748277
[TBL] [Abstract][Full Text] [Related]
17. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Falck AK; Fernö M; Bendahl PO; Rydén L
BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
[TBL] [Abstract][Full Text] [Related]
18. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
19. Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.
Bitencourt A; Rossi Saccarelli C; Morris EA; Flynn J; Zhang Z; Khan A; Gillespie E; Cahlon O; Mueller B; Cuaron JJ; McCormick B; Powell SN; Plitas G; Razavi P; Pinker K; Riedl CC; Sutton EJ; Braunstein LZ
JAMA Netw Open; 2020 Oct; 3(10):e2018790. PubMed ID: 33034638
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Distant Recurrence Using EndoPredict Among Women with ER
Filipits M; Dubsky P; Rudas M; Greil R; Balic M; Bago-Horvath Z; Singer CF; Hlauschek D; Brown K; Bernhisel R; Kronenwett R; Lancaster JM; Fitzal F; Gnant M
Clin Cancer Res; 2019 Jul; 25(13):3865-3872. PubMed ID: 31064782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
